MCM-41 as a useful vector for rutin topical formulations: Synthesis, characterization and testing

International Journal of Pharmaceutics

Volumn 457, Issue 1, 2013, Pages 177-186

  Berlier, Gloria ^a   Gastaldi, Lucia ^a   Sapino, Simona ^a   Miletto, Ivana ^a   Bottinelli, Emanuela ^a   Chirio, Daniela ^a   Ugazio, Elena ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Antiradical activity; Flavonoids; Mesoporous silica nanoparticles; Photostability; Skin permeation

Indexed keywords

MCM 41; RUTOSIDE; SILICON DIOXIDE;

ANTIOXIDANT ACTIVITY; ARTICLE; CHEMICAL INTERACTION; DEGRADATION; DRUG FORMULATION; DRUG SYNTHESIS; EX VIVO STUDY; IMMOBILIZATION; INFRARED SPECTROSCOPY; ISOTHERM; LIPID COMPOSITION; MOLECULAR INTERACTION; PH; PHYSICAL CHEMISTRY; POROSITY; PRIORITY JOURNAL; SURFACE PROPERTY; ULTRAVIOLET RADIATION; VOLUMETRY; X RAY DIFFRACTION;

ANTIRADICAL ACTIVITY; FLAVONOIDS; MESOPOROUS SILICA NANOPARTICLES; PHOTOSTABILITY; SKIN PERMEATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIOXIDANTS; CHELATING AGENTS; FERROZINE; RUTIN; SILICON DIOXIDE; SKIN; SKIN ABSORPTION; SURFACE PROPERTIES; SWINE; ULTRAVIOLET RAYS;

EID: 84885449132     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.09.018     Document Type: Article

References (49)

1. V. Ambrogi, L. Perioli, C. Pagano, L. Latterini, F. Marmottini, M. Ricci, and C. Rossi MCM-41 for furosemide dissolution improvement Microporous. Mesoporous. Mater. 147 2012 343 349
2. V. Ambrogi, L. Zatterini, F. Marmottini, C. Pagano, and M. Ricci Mesoporous silicate MCM-41 as a particulate carrier for octyl methoxycinnamate: Sunscreen release and photostability J. Pharm. Sci. 102 2013 1468 1475
3. M.W. Ambrogio, C.R. Thomas, Y.-L. Zhao, J.I. Zink, and J.F. Stoddart Mechanized silica nanoparticles: a new frontier in theranostic nanomedicine Acc. Chem. Res. 44 2011 903 913
4. J. Andersson, J. Rosenholm, S. Areva, and M. Linden Influences of material characteristics on ibuprofen drug loading and release profiles from ordered micro- and mesoporous silica matrices Chem. Mater. 16 2004 4160 4167
5. J.S. Beck, J.C. Vartuli, W.J. Roth, M.E. Leonowicz, C.T. Kresge, K.D. Schmitt, C.T.W. Chu, D.H. Olson, and S.E. W A new family of mesoporous molecular sieves prepared with liquid crystal templates J. Am. Chem. Soc. 114 1992 10834 10843
6. G. Berlier, L. Gastaldi, E. Ugazio, I. Miletto, P. Iliade, and S. Sapino Stabilization of quercetin flavonoid in MCM-41 mesoporous silica: positive effect of surface functionalization J. Colloid Interface Sci. 393 2013 109 118
7. I. Braschi, G. Gatti, C. Bisio, G. Berlier, V. Sacchetto, M. Cossi, and L. Marchese The role of silanols in the interactions between methyl tert-butyl ether and high-silica faujasite Y: an infrared spectroscopy and computational model study J. Phys. Chem. C 116 2012 6943 6952
8. V. Cauda, L. Muehlstein, B. Onida, and T. Bein Tuning drug uptake and release rates through different morphologies and pore diameters of confined mesoporous silica Microporous Mesoporous Mater. 118 2009 435 442
9. S. Dall'Acqua, G. Miolo, G. Innocenti, and S. Caffieri The photodegradation of quercetin: relation to oxidation Molecules 17 2012 8898 8907
10. A.J. Di Pasqua, K.K. Sharma, Y.-L. Shi, B.B. Toms, W. Ouellette, J.C. Dabrowiak, and T. Asefa Cytotoxicity of mesoporous silica nanomaterials J. Inorg. Biochem. 102 2008 1416 1423
11. T.C.P. Dinis, V.M.C. Madeira, and L.A. Almeida Action of phenolic derivatives (acetaminophen, salicylate, and 5-aminosalicylate) as inhibitors of membrane lipid peroxidation and peroxyl radical scavengers Arch. Biochem. Biophys. 315 1994 161 169 (Pubitemid 24351051)
12. D.P. Ferris, J. Lu, C. Gothard, R. Yanes, C.R. Thomas, J.-C. Olsen, J.F. Stoddart, F. Tamanoi, and J.I. Zink Synthesis of biomolecule-modified mesoporous silica nanoparticles for targeted hydrophobic drug delivery to cancer cells Small 7 2011 1816 1826
13. D.P. Ferris, Y.-L. Zhao, N.M. Khashab, H.A. Khatib, J.F. Stoddart, and J.I. Zink Light-operated mechanized nanoparticles J. Am. Chem. Soc. 131 2009 1686 1688
14. T. Fontecave, C. Sanchez, T. Azais, and C. Boissiere Chemical modification as a versatile tool for tuning stability of silica based mesoporous carriers in biologically relevant conditions Chem. Mater. 24 2012 4326 4336
15. 2 leaching in water Chem. Mater. 21 2009 4135 4145
16. L. Gastaldi, E. Ugazio, S. Sapino, P. Iliade, I. Miletto, and G. Berlier Mesoporous silica as a carrier for topical application: the Trolox case study Phys. Chem. Chem. Phys. 14 2012 11318 11326
17. E. Graefe, J. Wittig, S. Mueller, A. Riethling, B. Uehleke, B. Drewelow, H. Pforte, G. Jacobasch, H. Derendorf, and M. Veit Pharmacokinetics and bioavailability of quercetin glycosides in humans J. Clin. Pharmacol. 41 2001 492 499 (Pubitemid 32381866)
18. I. Gulcin Antioxidant and antiradical activities of l-Carnitine Life Sci. 78 2006 803 811 (Pubitemid 43082302)
19. X. Huang, J. Zhuang, X. Teng, L. Li, D. Chen, X. Yan, and F. Tang The promotion of human malignant melanoma growth by mesoporous silica nanoparticles through decreased reactive oxygen species Biomaterials 31 2010 6142 6153
20. I. Izquierdo-Barba, S. Sanchez-Salcedo, M. Colilla, M.J. Feito, C. Ramirez-Santillan, M.T. Portoles, and M. Vallet-Regí Inhibition of bacterial adhesion on biocompatible zwitterionic SBA-15 mesoporous materials Acta Biomater. 7 2011 2977 2985
21. M. Karthick, and P.S.M. Prince Preventive effect of rutin, a bioflavonoid, on lipid peroxides and antioxidants in isoproterenol-induced myocardial infarction in rats J. Pharm. Pharmacol. 58 2006 701 707
22. Z. Li, J.C. Barnes, A. Bosoy, J.F. Stoddart, and J.I. Zink Mesoporous silica nanoparticles in biomedical applications Chem. Soc. Rev. 41 2012 2590 2605
23. Y.-S. Lin, N. Abadeer, and C.L. Haynes Stability of small mesoporous silica nanoparticles in biological media Chem. Commun. 47 2011 532 534
24. M. Liong, B. France, K.A. Bradley, and J.I. Zink Antimicrobial activity of silver nanocrystals encapsulated in mesoporous silica nanoparticles Adv. Mater. 21 2009 1684 1689
25. J. Lu, Z. Li, J.I. Zink, and F. Tamanoi In vivo tumor suppression efficacy of mesoporous silica nanoparticles-based drug-delivery system: enhanced efficacy by folate modification Nanomedicine 8 2012 212 220
26. J. Lu, M. Liong, Z. Li, J.I. Zink, and F. Tamanoi Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals Small 6 2010 1794 1805
27. V. Mamaeva, J.M. Rosenholm, L.T. Bate-Eya, L. Bergman, E. Peuhu, A. Duchanoy, L.E. Fortelius, S. Landor, D.M. Toivola, M. Linden, and C. Sahlgren Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of notch signaling in cancer Mol. Ther. 19 2011 1538 1546
28. M. Manzano, M. Colilla, and M. Vallet-Regí Drug delivery from ordered mesoporous matrices Expert Opin. Drug Deliv. 6 2009 1383 1400
29. R. Mauludin, R.H. Müller, and C.M. Keck Kinetic solubility and dissolution velocity of rutin nanocrystals Eur. J. Pharm. Sci. 36 2009 502 510
30. H. Meng, M. Xue, T. Xia, Z. Ji, D.Y. Tarn, J.I. Zink, and A.E. Nel Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model ACS Nano 5 2011 4131 4144
31. H. Meng, M. Xue, J.I. Zink, and A.E. Nel Development of pharmaceutically adapted mesoporous silica nanoparticles platform J. Phys. Chem. Lett. 3 2012 358 359
32. H. Meng, S. Yang, Z. Li, T. Xia, J. Chen, Z. Ji, H. Zhang, X. Wang, S. Lin, C. Huang, Z.H. Zhou, J.I. Zink, and A.E. Nel Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism ACS Nano 5 2011 4434 4447
33. E. Middleton, C. Kandaswami, and T. Theoharides The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer Pharm. Rev. 52 2000 673 751
34. R. Mortera, S. Fiorilli, E. Garrone, E. Verne, and B. Onida Pores occlusion in MCM-41 spheres immersed in SBF and the effect on ibuprofen delivery kinetics: a quantitative model Chem. Eng. J. 156 2010 184 192
35. K.M. Parida, and D. Rath Amine functionalized MCM-41: an active and reusable catalyst for Knoevenagel condensation reaction J. Mol. Catal. A: Chem. 310 2009 93 100
36. M. Rabiskova, T. Bautzova, J. Gajdziok, K. Dvorackova, A. Lamprecht, Y. Pellequer, and J. Spilkova Coated chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease: in vitro characteristics and in vivo evaluation Int. J. Pharm. 422 2012 151 159
37. J.M. Rosenholm, and M. Linden Towards establishing structure-activity relationships for mesoporous silica in drug delivery applications J. Controlled Release 128 2008 157 164
38. J.M. Rosenholm, V. Mamaeva, C. Sahlgren, and M. Linden Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage Nanomedicine 7 2012 111 120
39. J.M. Rosenholm, E. Peuhu, J.E. Eriksson, C. Sahlgren, and M. Linden Targeted intracellular delivery of hydrophobic agents using mesoporous hybrid silica nanoparticles as carrier systems Nano Lett. 9 2009 3308 3311
40. M. Scalia Incorporation of quercetin in lipid microparticles: effect on photo- and chemical-stability J. Pharm. Biomed. Anal. 49 2009 90 94
41. G. Socrates Infrared and Raman characteristic group frequencies: tables and charts third ed. 2004 John Wiley & Sons Ltd. Chichester, UK
42. Z. Tao, M.P. Morrow, T. Asefa, K.K. Sharma, C. Duncan, A. Anan, H.S. Penefsky, J. Goodisman, and A.-K. Souid Mesoporous silica nanoparticles inhibit cellular respiration Nano Lett. 8 2008 1517 1526
43. S. Tosoni, B. Civalleri, F. Pascale, and P. Ugliengo Hydroxylated crystalline edingtonite silica faces as models for the amorphous silica surface J. Phys.: Conf. Ser. 117 2008 012026
44. B. Trewyn, J. Nieweg, Y. Zhao, and V. Lin Biocompatible mesoporous silica nanoparticles with different morphologies for animal cell membrane penetration Chem. Eng. J. 137 2008 23 29 (Pubitemid 351226642)
45. M. Vallet-Regí, F. Balas, and D. Arcos Mesoporous materials for drug delivery Angew. Chem. Int. Ed. Engl. 46 2007 7548 7558 (Pubitemid 47556998)
46. M. Vallet-Regí, A. Ramila, R.P. del Real, and J. Pérez-Pariente A new property of MCM-41: drug delivery system Chem. Mater. 13 2001 308 311 (Pubitemid 32199334)
47. J. Vivero-Escoto, I. Slowing, B. Trewyn, and V. Lin Mesoporous silica nanoparticles for intracellular controlled drug delivery Small 18 2010 1952 1967
48. S. Wang Ordered mesoporous materials for drug delivery Microporous Mesoporous Mater. 117 2009 1 9
49. B. Yang, A. Kotani, K. Arai, and F. Kusu Estimation of the antioxidant activities of flavonoids from their oxidation potentials Anal. Sci. 17 2001 599 604 (Pubitemid 33642942)